Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01885312 · ClinicalTrials.gov registry record · NA
Tailored Mobile Text Messaging to Reduce Problem Drinking
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 174
- Enrollment target
NCT01885312: Completed NA study, sponsored by Northwell Health.
NCT01885312 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 174 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01885312, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
Study Summary
This study is designed to develop and test a tailored adaptive text messaging/short message service (SMS) intervention for individuals interested in stopping or reducing their alcohol consumption; and test and compare it to tailored but static, once a day messaging, gain framed messaging, and ecological momentary assessment only.
Interventions
- BEHAVIORAL Adaptive Tailored Intervention
- BEHAVIORAL Consequence-based Intervention
- BEHAVIORAL Tailored, not adaptive, based Intervention
- OTHER Assessment only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT01885312 record still lists
NCT01885312 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 4 interventions - of which Adaptive Tailored Intervention is the first listed.
NCT01885312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01885312 about?
NCT01885312 is a clinical study titled "Tailored Mobile Text Messaging to Reduce Problem Drinking". This study is designed to develop and test a tailored adaptive text messaging/short message service (SMS) intervention for individuals interested in stopping or reducing their alcohol consumption; and test and compare it to tailored but static, once a day messaging, gain framed messaging, and ecolog...
What is the current status of trial NCT01885312?
This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2014-02. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01885312?
The interventions under investigation include: Adaptive Tailored Intervention (BEHAVIORAL), Consequence-based Intervention (BEHAVIORAL), Tailored, not adaptive, based Intervention (BEHAVIORAL), Assessment only (OTHER).
Who is sponsoring clinical trial NCT01885312?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01885312's enrollment target sits among peer trials
174 610th of 2000 higher than 1,390 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
- NCT04729114 · 174 participants · Phase 1
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- NCT04884035 · 174 participants · Phase 1
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
- NCT05075980 · 174 participants · Phase 2
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia